BDBM50328136 6-(1H-pyrazol-4-yl)-N-(4-(trifluoromethoxy)phenyl)pyrimidin-4-amine::CHEMBL1257656::US9670214, TABLE 16.43
SMILES: FC(F)(F)Oc1ccc(Nc2cc(ncn2)-c2cn[nH]c2)cc1
InChI Key: InChIKey=YQXVNNKJNHKVLW-UHFFFAOYSA-N
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bcr-Abl (Homo sapiens (Human)) | BDBM50328136 (6-(1H-pyrazol-4-yl)-N-(4-(trifluoromethoxy)phenyl)...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | n/a | 43 | n/a | n/a | n/a | n/a | n/a |
Harvard Medical School Curated by ChEMBL | Assay Description Inhibition of Bcr-Abl in mouse BA/F3 cells | J Med Chem 53: 6934-46 (2010) Article DOI: 10.1021/jm100555f BindingDB Entry DOI: 10.7270/Q2DJ5FTW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
BCR/ABL fusion protein (T351I) (Homo sapiens (Human)) | BDBM50328136 (6-(1H-pyrazol-4-yl)-N-(4-(trifluoromethoxy)phenyl)...) | PDB GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7.5 | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; THE SCRIPPS RESEARCH INSTITUTE US Patent | Assay Description In vitro kinase assays were carried out by using recombinant murine c-abl containing SH3, SH2 and kinase domains (residues 46-531) and full length im... | US Patent US9670214 (2017) BindingDB Entry DOI: 10.7270/Q2000086 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
BCR/ABL fusion protein isoform X3 (Homo sapiens (Human)) | BDBM50328136 (6-(1H-pyrazol-4-yl)-N-(4-(trifluoromethoxy)phenyl)...) | PDB UniProtKB/TrEMBL GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | n/a | n/a | 90 | n/a | n/a | n/a | n/a | 7.5 | n/a |
DANA-FARBER CANCER INSTITUTE, INC.; THE SCRIPPS RESEARCH INSTITUTE US Patent | Assay Description In vitro kinase assays were carried out by using recombinant murine c-abl containing SH3, SH2 and kinase domains (residues 46-531) and full length im... | US Patent US9670214 (2017) BindingDB Entry DOI: 10.7270/Q2000086 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcr-Abl (Homo sapiens (Human)) | BDBM50328136 (6-(1H-pyrazol-4-yl)-N-(4-(trifluoromethoxy)phenyl)...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | n/a | n/a | 90 | n/a | n/a | n/a | n/a |
Harvard Medical School Curated by ChEMBL | Assay Description Inhibition of Bcr-Abl in mouse BA/F3 cells | J Med Chem 53: 6934-46 (2010) Article DOI: 10.1021/jm100555f BindingDB Entry DOI: 10.7270/Q2DJ5FTW | |||||||||||
More data for this Ligand-Target Pair |